DLA PharmaceuticalsTypically replies within 1 hour

DLA Pharmaceuticals is a dynamic and research-driven pharmaceutical company dedicated to advancing scientific discovery by providing high-quality, research-grade products.
Our mission is to support scientists, academic institutions, and biotech industries with reliable tools that enable breakthrough innovations in medicine, biotechnology, and life sciences.

Quick Links

Home
Products
About Us
Contact

Resources

Blog
Search Products
Categories

Contact Us

+91 9899965625
sales@dlapharmaceuticals.com info@dlapharmaceuticals.com
201, 2nd floor, Eldeco Center, Block A
Shivalik Colony, Malviya Nagar, South Delhi
New Delhi, 110017

Terms and Conditions
Privacy Policy

DLA PharmaceuticalsTypically replies within 1 hour

+91 9899965625

DLA PharmaceuticalsTypically replies within 1 hour

Quick Links

Home
Products
About Us
Contact

Resources

Blog
Search Products
Categories

Contact Us

+91 9899965625
sales@dlapharmaceuticals.com info@dlapharmaceuticals.com
201, 2nd floor, Eldeco Center, Block A
Shivalik Colony, Malviya Nagar, South Delhi
New Delhi, 110017

Terms and Conditions
Privacy Policy

DLA PharmaceuticalsTypically replies within 1 hour

Human iPSC From Fibroblast-Rett Syndrome, Congenital Variant | DLA Pharmaceuticals

Cell & Gene TherapyPrimary Cells

Human iPSC From Fibroblast-Rett Syndrome, Congenital Variant

CAT Number

ABC-SC126G

Unit Size

1 vial

Updated

March 16, 2026

Product Description

Product Category: Stem Cells|Induced Pluripotent Stem Cells (iPSCs)|Induced Pluripotent Stem Cells (iPSCs) Product Type: Human Induced Pluripotent Stem Cells Recommended Medium & Supplement: nan

Primary Cells

Interested in this product?

Contact our team for pricing, availability, and technical support.

Human iPSC From Fibroblast-Rett Syndrome, Congenital Variant

Product Description

Primary Cells

Interested in this product?

Browse More Products